Literature DB >> 20151199

Disease mechanisms and protein structures in fatty acid oxidation defects.

Niels Gregersen1, Rikke K J Olsen.   

Abstract

In fatty acid oxidation defects, the majority of gene variations are of the missense type and, therefore, prone to inducing misfolding in the resulting mutant protein. The fate of the mutant protein depends on the nature of the gene variation and other genetic factors as well as cellular and environmental factors. Since it has been shown that certain fatty acid oxidation enzyme proteins, exemplified by mutant medium-chain and short-chain acyl-CoA dehydrogenases as well as electron transfer flavoprotein and electron transfer flavoprotein dehydrogenase, may accumulate during cellular stress, e.g. elevated temperature, there is speculation about how such proteins may disturb the integrity of the putative fatty acid oxidation metabolone, in which the two flavoproteins link the matrix-located acyl-CoA dehydrogenases to the respiratory chain in the mitochondrial inner membrane. However, since studies so far have not been able to define the fatty acid oxidation metabolone, it is concluded that new concepts and refined techniques are required to answer these questions and thereby contribute to the elucidation of the cellular pathophysiology and the genotype-phenotype relationship in fatty acid oxidation defects.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20151199     DOI: 10.1007/s10545-010-9046-1

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  33 in total

1.  Misfolding, degradation, and aggregation of variant proteins. The molecular pathogenesis of short chain acyl-CoA dehydrogenase (SCAD) deficiency.

Authors:  Christina Bak Pedersen; Peter Bross; Vibeke Stenbroen Winter; Thomas Juhl Corydon; Lars Bolund; Kim Bartlett; Jerry Vockley; Niels Gregersen
Journal:  J Biol Chem       Date:  2003-09-23       Impact factor: 5.157

Review 2.  Dynamics driving function: new insights from electron transferring flavoproteins and partner complexes.

Authors:  Helen S Toogood; David Leys; Nigel S Scrutton
Journal:  FEBS J       Date:  2007-10-17       Impact factor: 5.542

Review 3.  Control of mitochondrial beta-oxidation flux.

Authors:  Simon Eaton
Journal:  Prog Lipid Res       Date:  2002-05       Impact factor: 16.195

4.  Co-overexpression of bacterial GroESL chaperonins partly overcomes non-productive folding and tetramer assembly of E. coli-expressed human medium-chain acyl-CoA dehydrogenase (MCAD) carrying the prevalent disease-causing K304E mutation.

Authors:  P Bross; B S Andresen; V Winter; F Kräutle; T G Jensen; A Nandy; S Kølvraa; S Ghisla; L Bolund; N Gregersen
Journal:  Biochim Biophys Acta       Date:  1993-10-20

5.  Molecular cloning and expression of a cDNA encoding human electron transfer flavoprotein-ubiquinone oxidoreductase.

Authors:  S I Goodman; K M Axtell; L A Bindoff; S E Beard; R E Gill; F E Frerman
Journal:  Eur J Biochem       Date:  1994-01-15

Review 6.  Enzyme replacement and enhancement therapies for lysosomal diseases.

Authors:  R J Desnick
Journal:  J Inherit Metab Dis       Date:  2004       Impact factor: 4.982

7.  Role of flavinylation in a mild variant of multiple acyl-CoA dehydrogenation deficiency: a molecular rationale for the effects of riboflavin supplementation.

Authors:  Bárbara J Henriques; João V Rodrigues; Rikke K Olsen; Peter Bross; Cláudio M Gomes
Journal:  J Biol Chem       Date:  2008-12-16       Impact factor: 5.157

8.  A mitochondrial protein compendium elucidates complex I disease biology.

Authors:  David J Pagliarini; Sarah E Calvo; Betty Chang; Sunil A Sheth; Scott B Vafai; Shao-En Ong; Geoffrey A Walford; Canny Sugiana; Avihu Boneh; William K Chen; David E Hill; Marc Vidal; James G Evans; David R Thorburn; Steven A Carr; Vamsi K Mootha
Journal:  Cell       Date:  2008-07-11       Impact factor: 41.582

9.  Mitochondrial fatty acid oxidation defects--remaining challenges.

Authors:  Niels Gregersen; Brage S Andresen; Christina B Pedersen; Rikke K J Olsen; Thomas J Corydon; Peter Bross
Journal:  J Inherit Metab Dis       Date:  2008-10-07       Impact factor: 4.982

10.  ETFDH mutations as a major cause of riboflavin-responsive multiple acyl-CoA dehydrogenation deficiency.

Authors:  Rikke K J Olsen; Simon E Olpin; Brage S Andresen; Zofia H Miedzybrodzka; Morteza Pourfarzam; Begoña Merinero; Frank E Frerman; Michael W Beresford; John C S Dean; Nanna Cornelius; Oluf Andersen; Anders Oldfors; Elisabeth Holme; Niels Gregersen; Douglass M Turnbull; Andrew A M Morris
Journal:  Brain       Date:  2007-06-20       Impact factor: 13.501

View more
  10 in total

1.  Prevalence of Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency in Estonia.

Authors:  K Joost; K Ounap; R Zordania; M-L Uudelepp; R K Olsen; K Kall; K Kilk; U Soomets; T Kahre
Journal:  JIMD Rep       Date:  2011-09-06

2.  Complex changes in the liver mitochondrial proteome of short chain acyl-CoA dehydrogenase deficient mice.

Authors:  Wei Wang; Al-Walid Mohsen; Guy Uechi; Emanuel Schreiber; Manimalha Balasubramani; Billy Day; M Michael Barmada; Jerry Vockley
Journal:  Mol Genet Metab       Date:  2014-03-12       Impact factor: 4.797

Review 3.  Mitochondrial proteomics--a tool for the study of metabolic disorders.

Authors:  Niels Gregersen; Jakob Hansen; Johan Palmfeldt
Journal:  J Inherit Metab Dis       Date:  2012-04-17       Impact factor: 4.982

Review 4.  Phenylketonuria as a model for protein misfolding diseases and for the development of next generation orphan drugs for patients with inborn errors of metabolism.

Authors:  Ania C Muntau; Søren W Gersting
Journal:  J Inherit Metab Dis       Date:  2010-09-08       Impact factor: 4.982

Review 5.  Short-chain acyl-CoA dehydrogenase deficiency: from gene to cell pathology and possible disease mechanisms.

Authors:  Zahra Nochi; Rikke Katrine Jentoft Olsen; Niels Gregersen
Journal:  J Inherit Metab Dis       Date:  2017-05-17       Impact factor: 4.982

6.  Acylcarnitine Profiles in HIV-Exposed, Uninfected Neonates in the United States.

Authors:  Brian Kirmse; Tzy-Jyun Yao; Sean Hofherr; Deborah Kacanek; Paige L Williams; Charlotte V Hobbs; Rohan Hazra; William Borkowsky; Russell B Van Dyke; Marshall Summar
Journal:  AIDS Res Hum Retroviruses       Date:  2016-01-19       Impact factor: 2.205

7.  High prevalence of carriers of variant c.1528G>C of HADHA gene causing long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (LCHADD) in the population of adult Kashubians from North Poland.

Authors:  Bogusław Nedoszytko; Alicja Siemińska; Dominik Strapagiel; Sławomir Dąbrowski; Marcin Słomka; Marta Sobalska-Kwapis; Błażej Marciniak; Jolanta Wierzba; Jarosław Skokowski; Marcin Fijałkowski; Roman Nowicki; Leszek Kalinowski
Journal:  PLoS One       Date:  2017-11-02       Impact factor: 3.240

Review 8.  Recent Advances in the Pathophysiology of Fatty Acid Oxidation Defects: Secondary Alterations of Bioenergetics and Mitochondrial Calcium Homeostasis Caused by the Accumulating Fatty Acids.

Authors:  Alexandre Umpierrez Amaral; Moacir Wajner
Journal:  Front Genet       Date:  2020-11-27       Impact factor: 4.599

9.  Targeting CPT1A-mediated fatty acid oxidation sensitizes nasopharyngeal carcinoma to radiation therapy.

Authors:  Zheqiong Tan; Lanbo Xiao; Min Tang; Fang Bai; Jiangjiang Li; Liling Li; Feng Shi; Namei Li; Yueshuo Li; Qianqian Du; Jingchen Lu; Xinxian Weng; Wei Yi; Hanwen Zhang; Jia Fan; Jian Zhou; Qiang Gao; José N Onuchic; Ann M Bode; Xiangjian Luo; Ya Cao
Journal:  Theranostics       Date:  2018-03-22       Impact factor: 11.556

Review 10.  Pathophysiology of fatty acid oxidation disorders and resultant phenotypic variability.

Authors:  Simon E Olpin
Journal:  J Inherit Metab Dis       Date:  2013-05-15       Impact factor: 4.982

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.